Revenue: The sum of all revenue fields included for a company's operating activities.
Foghorn Therapeutics Inc. (FHTX) had Revenue of $9.25M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$9.25M |
$-21.66M |
|
-- |
|
$9.25M |
|
$33.12M |
|
$-23.88M |
|
$2.21M |
|
$-21.66M |
|
$-21.66M |
|
$-21.66M |
|
$-21.66M |
|
$-21.66M |
|
$-21.66M |
|
$-23.88M |
|
$-23.38M |
|
62.98M |
|
62.98M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$163.24M |
|
$1.92M |
|
$34.87M |
|
$198.10M |
|
$59.74M |
|
-- |
|
$246.87M |
|
$306.60M |
|
$-108.50M |
|
$-108.50M |
|
$-108.50M |
|
56.66M |
|
| Cash Flow Statement Financials | |
$-86.10M |
|
$112.04M |
|
$1.02M |
|
$57.16M |
|
$84.13M |
|
$26.96M |
|
$10.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-258.22% |
|
-258.22% |
|
-- |
|
-234.28% |
|
-234.28% |
|
$-86.15M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
19.97% |
|
19.97% |
|
-10.94% |
|
19.97% |
|
$-1.92 |
|
$-1.37 |
|
$-1.37 |
|